Firm. FDA records under its name, each linked to the record.
As of Nov 22, 2026, FDA's public records list Nanjing Hanxin Pharmaceutical Technology with 1 warning letter. The most recent is a warning letter dated Nov 3, 2026: Warning letter: Supplier controls, Quality unit.
Drug approvals, 510(k) clearances, recalls and letters, 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Date | Record | Source |
|---|---|---|
| Nov 3, 2026 | Warning letter: Supplier controls, Quality unitCDER | Warning letter |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.